While emerging research explores potential anti-inflammatory properties of GLP-1 receptor agonists, tirzepatide has no FDA approval for autoimmune conditions such as rheumatoid arthritis, lupus, or inflammatory bowel disease
Slows gastric emptying: Results in slower digestion, contributing to better post-meal glucose and appetite control
Without insurance, GLP-1s often cost between $900 and $1,400 a month, or up to $12,000 a year, according to the National Conference of State Legislatures
The expanded MACE definition included hospitalization for heart failure, a common event in ESRD, and therefore cardiovascular findings should be interpreted descriptively rather than as evidence of benefit or harm
In one trial, the condition occurred in 4% of those on Wegovy who had type 2 diabetes and overweight compared to 2.7% of the placebo group